Integrin α6-targeted SPECT Imaging of Breast Cancer
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
A novel radiotracer 99mTc-RWY targeting Integrin α6 was developed, and the pilot
first-in-human study for SPECT imaging of breast cancer was performed in seven healthy
volunteers and two breast cancer patients to assess the safety and potential clinical
applications of 99mTc-RWY.
Phase:
Early Phase 1
Details
Lead Sponsor:
Bing Jia Peking University
Collaborators:
China-Japan Union Hospital, Jilin University Sun Yat-sen University